Patents Issued in October 9, 2018
-
Patent number: 10093727Abstract: Antibodies are provided that specifically bind seven human ELR+ CXC chemokines. The antibodies of the invention are useful for treating various inflammatory/autoimmune diseases, such as inflammatory bowel disease (IBD), plaque psoriasis, and palmoplantar pustulosis; and cancer, such as renal cancer or ovarian cancer.Type: GrantFiled: September 5, 2017Date of Patent: October 9, 2018Assignee: Eli Lilly and CompanyInventors: Catherine Brautigam Beidler, Kristine Kay Kikly, Beth Ann Strifler, Derrick Ryan Witcher, Sudhakar Reddy Chintharlapalli
-
Patent number: 10093728Abstract: The present invention provides certain improved formulations of proteins. Specifically, the present invention provides use of certain excipients that are useful for stabilization of antibody preparations. Additionally, the novel formulations of the present invention prevents the formation of aggregates or fragments or modifications of protein in solution.Type: GrantFiled: March 5, 2013Date of Patent: October 9, 2018Assignee: CADILA HEALTHCARE LIMITEDInventors: Sanjeev Kumar Mendiratta, Sanjay Bandyopadhyay, Chintan G. Patel
-
Patent number: 10093729Abstract: This invention provides a novel means that allows efficient secretion and production of a target protein in a host cell. This invention concerns a novel polypeptide having an activity of improving the secretion productivity of a target protein, a gene comprising a nucleotide sequence encoding such polypeptide, a vector comprising such gene, a transformant obtained by transforming a host cell with such vector, and a method for producing a protein comprising a step of culturing such transformant and recovering a target protein from the culture product.Type: GrantFiled: June 25, 2014Date of Patent: October 9, 2018Assignees: KANEKA CORPORATION, NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGYInventors: Teruyuki Nishi, Kiyoshi Asai, Hiroko Hagiwara, Masayuki Machida
-
Patent number: 10093730Abstract: The invention provides interleukin-33 (IL-33) antibodies and methods of using the same.Type: GrantFiled: November 10, 2015Date of Patent: October 9, 2018Assignee: Genentech, Inc.Inventors: Philip E. Hass, Meredith Hazen, Yi-Chun Hsiao, Rajita Khosla, Gerald R. Nakamura, Dhaya Seshasayee, Menno Van Lookeren Campagne, Hongkang Xi, Wenwu Zhai, Jack Bevers, III, Nancy Chiang
-
Patent number: 10093731Abstract: Provided are various embodiments relating to anti-IL31 antibodies binding to canine IL31. Such antibodies can be used in methods to treat IL31-induced conditions in companion animals, such as canines, felines, and equines.Type: GrantFiled: March 23, 2017Date of Patent: October 9, 2018Assignee: Kindred Biosciences, Inc.Inventors: Shyr Jiann Li, Lam Nguyen, Hangjun Zhan
-
Patent number: 10093732Abstract: The present invention is directed to therapeutic methods using IL-6 antagonists such as antibodies and fragments thereof having binding specificity for IL-6 to prevent or treat thrombosis in diseases associated with abnormal blood coagulation or fibrinolysis. In preferred embodiments these patients will comprise those exhibiting elevated D-dimer or other coagulation cascade related proteins and optionally will further exhibit elevated C reactive protein prior to treatment. The subject therapies also may include the administration of other actives such as chemotherapeutics, anti-coagulants, statins, et al.Type: GrantFiled: November 5, 2015Date of Patent: October 9, 2018Assignee: ALDERBIO HOLDINGS LLCInventor: Jeffrey T. L. Smith
-
Patent number: 10093733Abstract: The disclosure provides binding proteins that specifically bind to LRP-8 and optionally cross the blood brain barrier (BBB), localize to the brain and/or localize to the spinal cord.Type: GrantFiled: December 11, 2015Date of Patent: October 9, 2018Assignee: AbbVie Inc.Inventors: Lorenzo Benatuil, Kangwen Deng, Denise Karaoglu Hanzatian, Maria A. Argiriadi
-
Patent number: 10093734Abstract: RGMb antagonists reduce undesirable immune responses associated with tissue or organ transplantation.Type: GrantFiled: November 3, 2016Date of Patent: October 9, 2018Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Everett Hurteau Meyer, Rosemarie H. Dekruyff, Panagiota Iliopoulou, Yuchiao Hsu, Magdiel Perez Cruz
-
Patent number: 10093735Abstract: The present disclosure provides binding proteins, such as antibodies, that bind beta klotho, including human beta klotho, and methods of their use.Type: GrantFiled: July 25, 2017Date of Patent: October 9, 2018Assignee: NGM Biopharmaceuticals, Inc.Inventors: Kalyani Mondal, Betty Chan Li, Yu Chen, Taruna Arora, Hugo Matern, Wenyan Shen
-
Patent number: 10093736Abstract: The present invention provides binding agents that contain a binding domain that is specific for CD3 allowing binding to T cells and a binding domain that is specific for a tumor-associated claudin molecule and methods of using these binding agents or nucleic acids encoding therefor for treating cancer.Type: GrantFiled: November 12, 2013Date of Patent: October 9, 2018Assignees: BIONTECH AG, TRON GGMBH, UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ, GANYMED PHARMACEUTICALS AGInventors: Ugur Sahin, Ozlem Tureci, Christiane Stadler, Julia Holland, Hayat Bahr-Mahmud, Tim Beissert, Laura Plum, Fabrice Le Gall, Arne Jendretzki, Markus Fiedler
-
Patent number: 10093737Abstract: Provided are methods of treating an autoimmune disease in a subject, or of suppressing transplant rejection in a subject, or of treating a cancer in a subject, as well as compositions therefor.Type: GrantFiled: February 7, 2014Date of Patent: October 9, 2018Assignee: Albert Einstein College of Medicine, Inc.Inventor: Xingxing Zang
-
Patent number: 10093738Abstract: The present invention is directed to diabody molecules and uses thereof in the treatment of a variety of diseases and disorders, including immunological disorders, infectious disease, intoxication and cancers. The diabody molecules of the invention comprise two polypeptide chains that associate to form at least two epitope binding sites, which may recognize the same or different epitopes on the same or differing antigens. Additionally, the antigens may be from the same or different molecules. The individual polypeptide chains of the diabody molecule may be covalently bound through non-peptide bond covalent bonds, such as, but not limited to, disulfide bonding of cysteine residues located within each polypeptide chain. In particular embodiments, the diabody molecules of the present invention further comprise an Fc region, which allows antibody-like functionality to engineered into the molecule.Type: GrantFiled: February 10, 2016Date of Patent: October 9, 2018Assignee: MacroGenics, Inc.Inventors: Leslie S. Johnson, Ling Huang
-
Patent number: 10093739Abstract: The present invention is directed to diabody molecules and uses thereof in the treatment of a variety of diseases and disorders, including immunological disorders, infectious disease, intoxication and cancers. The diabody molecules of the invention comprise two polypeptide chains that associate to form at least two epitope binding sites, which may recognize the same or different epitopes on the same or differing antigens. Additionally, the antigens may be from the same or different molecules. The individual polypeptide chains of the diabody molecule may be covalently bound through non-peptide bond covalent bonds, such as, but not limited to, disulfide bonding of cysteine residues located within each polypeptide chain. In particular embodiments, the diabody molecules of the present invention further comprise an Fc region, which allows antibody-like functionality to engineered into the molecule.Type: GrantFiled: February 17, 2016Date of Patent: October 9, 2018Assignee: MacroGenics, Inc.Inventors: Leslie S. Johnson, Ling Huang
-
Patent number: 10093740Abstract: The invention relates to a bispecific HER2-targeting agent comprising a.) a first polypeptide ligand that binds to HER2 extracellular domain 1, b.) a second polypeptide ligand that binds to HER2 extracellular domain 4 and c.) a linker covalently attaching said first polypeptide ligand to said second polypeptide ligand.Type: GrantFiled: October 14, 2013Date of Patent: October 9, 2018Assignee: Universitat ZurichInventors: Rastislav Tamaskovic, Martin Schwill, Andreas Pluckthun, Christian Jost
-
Patent number: 10093741Abstract: The present invention relates to conjugates including a chelating moiety of a metal complex thereof and a therapeutic or targeting moiety, methods for their production, and uses thereof.Type: GrantFiled: August 15, 2017Date of Patent: October 9, 2018Assignee: Fusion Pharmaceuticals Inc.Inventors: Eric Steven Burak, John Richard Forbes, Matthew David Burr Moran, Ryan Wayne Simms, John Fitzmaurice Valliant
-
Patent number: 10093742Abstract: This disclosure generally provides molecules that specifically engage glucocorticoid-induced TNFR-related protein (GITR), a member of the TNF receptor superfamily (TNFRSF). More specifically, the disclosure relates to multivalent and/or multispecific molecules that bind at least GITR.Type: GrantFiled: July 22, 2016Date of Patent: October 9, 2018Assignee: Inhibrx, Inc.Inventors: John C. Timmer, Kyle S. Jones, Amir S. Razai, Abrahim Hussain, Katelyn M. Willis, Quinn Deveraux, Brendan P. Eckelman
-
Patent number: 10093743Abstract: Provided herein is a method of diagnosing muscle specific tyrosine kinase specific autoimmune myasthenia gravis in an individual. Generally, in the method a level of muscle specific tyrosine kinase binding to B cells is determined in a sample from an individual. A significant increase in the level of muscle specific tyrosine kinase reactive B-cells compared to that in a healthy individual indicates the presence of muscle specific tyrosine kinase autoimmune myasthenia gravis. Also provided is a fluorophore-muscle specific tyrosine kinase conjugate and a kit comprising the same useful to test the frequency of muscle specific tyrosine kinase binding B cells expressing specific markers, for diagnosis or as biomarker for muscle specific tyrosine kinase autoimmune myasthenia gravis.Type: GrantFiled: August 26, 2015Date of Patent: October 9, 2018Inventor: Premkumar Christadoss
-
Patent number: 10093745Abstract: In various embodiments chimeric moieties (constructs) are provided that show significant efficacy against cancers. In certain embodiments the constructs comprise a targeting moiety that specifically binds CSPG4 attached to an interferon or to a mutant interferon. In certain embodiments, the constructs comprise anti-CSPG4 antibody attached to an interferon alpha (IFN-?) or to a mutant interferon alpha or to an interferon beta (IFN-?) or to a mutant interferon beta, or to an interferon gamma (IFN-?) or to a mutant interferon gamma.Type: GrantFiled: May 29, 2014Date of Patent: October 9, 2018Assignee: The Regents of the University of CaliforniaInventors: Sherie L. Morrison, John M. Timmerman, Kham M. Trinh
-
Patent number: 10093746Abstract: The present invention relates to compositions and methods of isolated polynucleotides that encode or polypeptides comprising glypican-3 (GPC3). The invention also includes a chimeric antigen receptor (CAR) wherein the CAR is able to target GPC3. The invention further includes methods of treating a subject or diagnosing and treating diseases, disorders or conditions associated with dysregulated glypican-3.Type: GrantFiled: September 3, 2015Date of Patent: October 9, 2018Assignees: The Trustees of the University of Pennsylvania, The United States of America as represented by the Department of Veterans AffairsInventor: David Kaplan
-
Patent number: 10093747Abstract: A method of producing a sugar liquid using a cellulose-containing biomass as a raw material includes (a) hydrolyzing a cellulose-containing biomass to produce an aqueous sugar solution and (b) filtering the obtained aqueous sugar solution through a reverse osmosis membrane to collect a purified sugar liquid from a feed side, while removing fermentation-inhibiting substances from a permeate side.Type: GrantFiled: May 28, 2014Date of Patent: October 9, 2018Assignee: Toray Industries, Inc.Inventors: Hiroyuki Kurihara, Atsushi Minamino, Masateru Ito, Hideki Sawai, Masayuki Hanakawa, Shin-ichi Minegishi, Katsushige Yamada
-
Patent number: 10093748Abstract: Processes disclosed are capable of converting biomass into high-crystallinity nanocellulose with surprisingly low mechanical energy input. In some variations, the process includes fractionating biomass with an acid (such as sulfur dioxide), a solvent (such as ethanol), and water, to generate cellulose-rich solids and a liquid containing hemicellulose and lignin; and mechanically treating the cellulose-rich solids to form nanofibrils and/or nanocrystals. The crystallinity of the nanocellulose material may be 80% or higher, translating into good reinforcing properties for composites. The nanocellulose material may include nanofibrillated cellulose, nanocrystalline cellulose, or both. In some embodiments, the nanocellulose material is hydrophobic via deposition of some lignin onto the cellulose surface. Optionally, sugars derived from amorphous cellulose and hemicellulose may be separately fermented, such as to monomers for various polymers.Type: GrantFiled: September 30, 2016Date of Patent: October 9, 2018Assignee: API Intellectual Property Holdings, LLCInventors: Kimberly Nelson, Theodora Retsina, Vesa Pylkkanen, Ryan O'Connor
-
Patent number: 10093749Abstract: Provided are exopolysaccharide produced by novel lactic acid bacteria having an IgA production promoting ability, a production method of the exopolysaccharide, a composition containing the exopolysaccharide, and the like.Type: GrantFiled: September 18, 2014Date of Patent: October 9, 2018Assignee: NITTO PHARMACEUTICAL INDUSTRIES, LTD.Inventors: Kenji Yamamoto, Chiaki Matsuzaki, Keiko Hisa
-
Patent number: 10093750Abstract: The invention relates to a modified diene elastomer comprising predominantly the entity functionalized in the middle of the chain by an alkoxysilane group, optionally partially or completely hydrolyzed to give silanol, bearing a tertiary amine functional group and the silicon atom of which bonds the two pieces of the chain, the chain ends of the modified diene elastomer being functionalized to at least 70 mol %, with respect to the number of moles of chain end, by an amine functional group.Type: GrantFiled: August 4, 2014Date of Patent: October 9, 2018Assignees: COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN, MICHELIN RECHERCHE ET TECHNIQUE S.A.Inventors: Charlotte Dire, Jean Marc Marechal, Nicolas Seeboth
-
Patent number: 10093751Abstract: The invention relates to a modified diene elastomer comprising predominantly the entity functionalized in the middle of the chain by an alkoxysilane group, optionally partially or completely hydrolyzed to give silanol, bearing an epoxide function and the silicon atom of which bonds the two pieces of the chain, the chain ends of the modified diene elastomer being functionalized to at least 70 mol %, with respect to the number of moles of chain end, by an amine function.Type: GrantFiled: October 29, 2014Date of Patent: October 9, 2018Assignees: COMPAGNIE GENERALE DES ESTABLISSEMENTS MICHELIN, MICHELIN RECHERCHE ET TECHNIQUE, S.A.Inventors: Charlotte Dire, Jean-Marc Marechal, Nicolas Seeboth
-
Patent number: 10093752Abstract: Disclosed herein is a preparation method of homopolymer nanoparticles without using a surfactant. The homopolymer nanoparticles prepared thereby are expected to be widely used not only as a template of a semiconductor metal oxide, a drug delivery system (DDS), an electron transport layer (ETL), and a seed having vertical structural shape, but also in a high precision field such as replacement of an organic device polystyrene bead film.Type: GrantFiled: June 13, 2014Date of Patent: October 9, 2018Assignee: GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGYInventors: Jae-Suk Lee, Santosh Kumar, Dong Woo Kim, Mohammad Changei, Hong-Joon Lee
-
Patent number: 10093753Abstract: Acrylic syrup polymer composition are provided by partially polymerizing a (meth)acrylic monomer mixture in the presence of a thiol chain transfer agent to produce a first syrup polymer composition comprising a low molecular weight solute (meth)acrylic copolymer and solvent monomers, quenching the chain transfer agent, further polymerizing the first syrup polymer composition to produce a second syrup polymer composition comprising the low molecular weight solute acrylic copolymer, a high molecular weight solute acrylic copolymer and optionally unreacted solvent monomers, optionally adding a crosslinker and photoinitiator; and further photopolymerizing the syrup polymer composition to produce a pressure-sensitive adhesive.Type: GrantFiled: December 1, 2015Date of Patent: October 9, 2018Assignee: 3M Innovative Properties CompanyInventors: Stefan H. Gryska, Hae-Seung Lee, Sung-Won Ha, Jenny B. Werness, Erick I. Soto Cantu, Babu N. Gaddam
-
Patent number: 10093754Abstract: Disclosed is a method of preparing a rare-earth alkyl phosphate solution, the method including step (a) of preparing an alkyl phosphate amine salt solution by reacting an organic amine with an alkyl phosphate in a first solvent; step (b) of preparing a rare-earth metal salt solution by reacting a rare-earth metal oxide with an acid in the second solvent; and step (c) of mixing and reacting the alkyl phosphate amine salt solution with the rare-earth metal salt solution.Type: GrantFiled: November 7, 2017Date of Patent: October 9, 2018Assignee: Korea Kumho Petrochemical Co., Ltd.Inventors: Hyung Jae Lee, Ji Hyun Heo
-
Patent number: 10093755Abstract: The present invention relates to a novel ligand compound, a transition metal compound and a catalyst composition including the transition metal compound. The novel ligand compound and the transition metal compound of the present invention may be usefully used as the catalyst of a polymerization reaction for preparing an olefin polymer having a low density relative to a CGC catalyst. In addition, a product having a low melt index (MI) and a high molecular weight may be manufactured using the olefin polymer polymerized using the catalyst composition including the transition metal compound.Type: GrantFiled: July 24, 2015Date of Patent: October 9, 2018Assignee: LG CHEM, LTD.Inventors: A Rim Kim, Dong Eun Kim, Jin Sam Gong, Seung Hwan Jung, Hae Woong Park
-
Patent number: 10093756Abstract: A method of producing a silane cross-linked polyethylene is disclosed which includes maleating a polyethylene polymer to form a maleated polyethylene and reacting the maleated polyethylene with a primary or secondary amino silane to form a silane-grafted polyethylene. The method further includes treating the silane-grafted polyethylene in a moisture curing process to form the silane cross-linked polyethylene.Type: GrantFiled: September 12, 2014Date of Patent: October 9, 2018Assignee: FINA TECHNOLOGY, INC.Inventors: Fengkui Li, John Ashbaugh, Jason Clark
-
Patent number: 10093757Abstract: The invention relates to a composition of an organofunctional silane compound, particularly of a mono-unsaturated silane compound, and of an organic acid or a precursor compound which releases said organic acid, and to a method for the production of polymer compounds such as granulates and/or finished products from thermoplastic base polymers and/or monomers and/or prepolymers of the thermoplastic base polymer utilizing the composition, the organic acid, or the precursor compound which releases said organic acid. The invention also relates to the produced polymers, filled plastics such as, for example, granulates, finished products, molded bodies and/or articles such as pipes or cables. In addition, the invention relates to a kit containing the composition.Type: GrantFiled: May 28, 2013Date of Patent: October 9, 2018Assignee: EVONIK DEGUSSA GMBHInventors: Kerstin Weissenbach, Aristidis Ioannidis, Bastian Bielawski
-
Patent number: 10093758Abstract: The present invention relates to a thermoplastic block copolymer comprising at least one PA block and at least one PB block. The PA block represents a polymer block comprising one or more units of monomer A, and the PB block represents a polymer block comprising one or more units of monomer B. Monomer A is a vinyl, acrylic, diolefin, nitrile, dinitrile, acrylonitrile monomer, a monomer with reactive functionality, or a crosslinking monomer. Monomer B is a radically polymerizable triglyceride or mixtures thereof, typically in the form of a plant or animal oil. The present invention also relates to a method of preparing a thermoplastic block copolymer or novel thermoplastic statistical copolymers by polymerizing a radically polymerizable monomer with a radically polymerizable triglyceride or mixtures thereof via reversible addition-fragmentation chain-transfer polymerization (RAFT), in the presence of an free radical initiator and a chain transfer agent.Type: GrantFiled: February 13, 2018Date of Patent: October 9, 2018Assignee: Iowa State University Research Foundation, Inc.Inventors: Eric W. Cochran, Ronald Christopher Williams, Nacu Hernandez, Andrew Cascione
-
Patent number: 10093759Abstract: A gas-phase process for making a propylene-based polymer in a fluidized-bed reactor, the reactor containing a fluidized bed including polymer product particles and a catalyst, the process having a set of quantitative criteria for maximum monomer partial pressure, maximum reactor temperature, and comonomer content(s) in the propylene-based polymer. The propylene-based polymer may be EBPT or BPRCP. The catalyst may include a catalyst/donor system comprising (1) a supported Ziegler-Natta pro-catalyst, (2) a co-catalyst, and (3) a mixed external electron donor system including (a) an activity limiting agent including at least one carboxylate ester functional group, and (b) a selectivity control agent.Type: GrantFiled: November 21, 2014Date of Patent: October 9, 2018Assignee: W. R. Grace & Co.-Conn.Inventors: Ping Cai, Matthew J. Fedec, Jeffrey D. Goad, Jan W. Van Egmond, Chai-Jing Chou
-
Patent number: 10093760Abstract: The present invention relates to a vinyl chloride-vinyl acetate copolymer, which may exhibit excellent tensile strength even during low-temperature processing, and a method of preparing the same. The copolymer according to the present invention may exhibit excellent tensile strength even during low-temperature processing by including a vinyl acetate-derived unit in a specific ratio and having a specific range of polydispersity index, for example, a polydispersity index of 2.1 to 2.4, at a degree of polymerization of 1,200 to 1,300. Thus, the vinyl chloride-vinyl acetate copolymer according to the present invention and the method of preparing the same may be easily applied to industries that need them, particularly, automotive industry or polyvinyl chloride resin industry.Type: GrantFiled: September 9, 2016Date of Patent: October 9, 2018Assignee: LG CHEM, LTD.Inventors: Chan Hee Lee, Kwang Jin Lee, Hyun Min Lee, Kyung Seog Youk
-
Patent number: 10093761Abstract: Described herein is a composition having a fluoropolymer derived from the polymerization of a monomer and a sulfinate-containing molecule, wherein the sulfinate-containing molecule is selected from the group consisting of Formula (I), Formula (II); and combinations thereof, wherein X1, X2, and X3 are each independently selected from H, F, Cl, a C1 to C4 alkyl group, and a C1 to C4 fluorinated alkyl group; R is a linking group; Z1 and Z2 are independently selected from F, CF3, and a perfluoroalkyl group; R1 and R2 are end-groups; p is 0 or 1; m is at least 1; and M is a cation. Also disclosed are methods of making and articles thereof.Type: GrantFiled: December 16, 2011Date of Patent: October 9, 2018Assignee: 3M Innovative Properties CompanyInventors: Gregg D. Dahlke, Denis Duchesne, Tatsuo Fukushi, Werner M. Grootaert, Miguel A. Guerra, Harald Kaspar, Larry A. Last, Peter J. Scott, Zai-Ming Qiu
-
Patent number: 10093762Abstract: Process for modifying a polymer comprising the steps of (a) mixing the polymer with a maleimide-functionalized mono-azide and/or a citraconimide-functionalized mono-azide at a temperature in the range 80-250° C. to form a functionalized polymer, and (b) reacting the functionalized polymer with a substance containing one or more functional groups that can react with a maleimide or citraconimide functional group.Type: GrantFiled: April 21, 2016Date of Patent: October 9, 2018Assignee: AKZO NOBEL CHEMICALS INTERNATIONAL B.V.Inventors: Waldo Joseph Elisabeth Beek, Auke Gerardus Talma
-
Patent number: 10093763Abstract: Stereoregular diblock polybutadiene composed of a polybutadiene block having a 1,4-cis structure and a polybutadiene block having a syndiotactic 1,2 structure. Said stereoregular diblock polybutadiene can be advantageously used in both the footwear industry (for example, in the production of soles for shoes) and in the production of tires for motor vehicles and/or trucks.Type: GrantFiled: November 3, 2014Date of Patent: October 9, 2018Assignee: versalis S.p.A.Inventors: Giovanni Ricci, Giuseppe Leone, Anna Sommazzi, Francesco Masi, Maria Francesca Pirini
-
Patent number: 10093764Abstract: A block copolymer is synthesized by polymerizing a silane-functionalized norbornene monomer in the presence of a catalyst system that includes a Ziegler-Natta catalyst and cocatalyst, followed by sequential addition and polymerization of a matrix-reactive functionalized norbornene monomer. In some embodiments, an enhanced substrate for a PCB is produced by applying the block copolymer to a substrate that includes glass fiber, followed by applying the base polymer to the substrate having the block copolymer applied thereto.Type: GrantFiled: August 24, 2015Date of Patent: October 9, 2018Assignee: International Business Machines CorporationInventors: Dylan J. Boday, Joseph Kuczynski, Timothy C. Mauldin
-
Patent number: 10093765Abstract: The present invention relates to alkoxysilane-functionalized allophanates, to methods for production thereof, and to the use thereof. In particular, the alkoxysilane-functionalized allophanate includes the reaction product of A) at least one alkoxysilane group-containing monourethane A) of the formula 1 Rn(OR1)3-nSi—R2—NH—(C?O)—OR3??formula 1, where R, R1, R2 and R3 are each independently hydrocarbyl radicals having 1-8 carbon atoms, which may be linear, branched or cyclic, or else may be integrated together to form a cyclic system, and n is 0-2, and B) at least one diisocyanate B), in a molar ratio of A) to B) of 3:1 to 1.5:1.Type: GrantFiled: June 14, 2017Date of Patent: October 9, 2018Assignee: Evonik Degussa GmbHInventors: Wiebke Stache, Tobias Unkelhäusser, Emmanouil Spyrou, Annegret Lilienthal, Iris Brückner, Jan Pfingsten
-
Patent number: 10093766Abstract: A two-component polyurethane composition with a viscosity of 20 to 3000 mPa·s (EN ISO 2555, 25° C.), containing i) 10 to 80 wt. % of at least one polyol with a number-average molecular weight of 200 g/mol to 3000 g/mol, ii) 5 to 70 wt. % of at least one polyisocyanate, iii) 0 to 10 wt. % of a catalyst, wherein the composition has an NCO:OH ratio of 2:1 to 1:2 and polyisocyanates are used, wherein 3 to 25 mol % of the NCO groups of the polyisocyanate are converted into carbodiimide and/or uretonimine. The two-component polyurethane compositions are used as matrix binders for fiber composite moldings.Type: GrantFiled: August 25, 2014Date of Patent: October 9, 2018Assignee: Henkel AG & Co. KGaAInventors: Andreas Ferencz, Lothar Thiele, Tamara Schmidt, Konrad Becker, Wolfgang Lupp, Dustin Ullmann, Oliver-Kei Okamoto
-
Patent number: 10093767Abstract: The invention relates to a multilayer structure comprising at least one layer of supramolecular material and one layer of rigid material, to a method for producing such a structure by casting a composition comprising a precursor of the supramolecular material, and to the uses of the structures produced, especially for applications where a dampening of impacts, vibrations and/or sound waves is desired, for example for producing locomotion vehicles such as automotive, rail, nautical, aeronautical or aerospace vehicles, or for the construction industry.Type: GrantFiled: April 10, 2014Date of Patent: October 9, 2018Assignee: Arkema FranceInventors: Jean-Pierre Disson, Bruno Van Hemelryck
-
Patent number: 10093768Abstract: Disclosed herein is an epoxy resin compositions comprising an epoxy component and a curing agent component, wherein the curing agent component is at least an aminoalkylimidazole curing agent, and wherein the epoxy component and the curing agent component react together at a temperature of about 100° C. to about 130° C. to form a substantially cured reaction product in about 10 minutes or less. Further disclosed are composite products formed from such epoxy resin compositions.Type: GrantFiled: June 2, 2016Date of Patent: October 9, 2018Assignee: Cytec Industrial Materials (Derby) LimitedInventor: Ian Aspin
-
Patent number: 10093769Abstract: An aluminum chelate-based latent curing agent for curing a thermosetting epoxy resin, in which an aluminum chelate-based curing agent is held in a porous resin obtained by, at the same time, subjecting a polyfunctional isocyanate compound to interfacial polymerization and subjecting a radical polymerizable compound to radical polymerization in the presence of a radical polymerization initiator, and the surface of the aluminum chelate-based latent curing agent has been subjected to inactivation treatment with an alkoxysilane coupling agent. An alkylalkoxysilane is preferred as the alkoxysilane coupling agent. The radical polymerizable compound preferably contains a polyfunctional radical polymerizable compound.Type: GrantFiled: August 31, 2015Date of Patent: October 9, 2018Assignee: DEXERIALS CORPORATIONInventor: Kazunobu Kamiya
-
Patent number: 10093770Abstract: A mixture may include at least one polymerizable species and at least one thermoresponsive supramolecular initiator complex involving a host-guest interaction. Processes for making resins may include mixing at least one polymerizable species with at least one thermoresponsive supramolecular initiator complex involving a host-guest interaction; subjecting the mixture to a temperature above about 30° C. thereby promoting the dissociation of the at least one thermoresponsive supramolecular initiator; and allowing the mixture to cure at the temperature for a period of time.Type: GrantFiled: August 12, 2013Date of Patent: October 9, 2018Assignees: SCHLUMBERGER TECHNOLOGY CORPORATION, FONDS DE L'ESPCI GEORGE CHARPAKInventors: Thomas Vidil, Francois-Genes Tournilhac, Ludwik Leibler
-
Patent number: 10093771Abstract: The present invention relates to a polyester resin with excellent solubility in generic solvents, especially with excellent solubility at a temperature of 0° C. or lower. According to the present invention, by using the polyester resin with excellent solubility in generic solvents, solubility at a lower temperature, especially the solubility at a temperature of 0° C. or lower, is enhanced, making it easier to prepare paints, coatings and the like. The polyester resin related to the present invention contains 0.05 to 0.5 mol of an isosorbide-derived structural unit and 0.015 to 0.4 mol of a trihydric or higher alcohol-derived structural unit relative to 1 mol of a polycarboxylic acid-derived structural unit.Type: GrantFiled: April 23, 2015Date of Patent: October 9, 2018Assignee: Mitsubishi Chemical CorporationInventors: Akifumi Kondo, Yoko Tamura, Masaaki Kiura, Asako Kaneko
-
Patent number: 10093772Abstract: The invention relates to a process for producing polyoxymethylene block copolymers, comprising the step of activating the DMC catalyst in the presence of an OH-terminated polymeric formaldehyde starter compound by means of a defined amount of alkylene oxide, optionally followed by polymerization with alkylene oxides, if necessary in the presence of other comonomers. The invention further relates to polyoxymethylene block copolymers that can be obtained by means of such a process and to the use of these for producing polyurethane polymers.Type: GrantFiled: April 1, 2015Date of Patent: October 9, 2018Assignee: COVESTRO DEUTSCHLAND AGInventors: Ilja Peckermann, Aurel Wolf, Jens Langanke, Christoph Gürtler, Jörg Hofmann
-
Patent number: 10093773Abstract: A fluoropolyether-containing polymer-modified silane having (1) is provided wherein Rf is a fluorooxyalkyl or fluorooxyalkylene-containing polymer residue, Y is a divalent to hexavalent hydrocarbon group, R is C1-C4 alkyl or phenyl, X is a hydrolyzable group, n is an integer of 1 to 3, m is an integer of 1 to 5, and ? is 1 or 2. A surface treating agent comprising the silane or partial hydrolytic condensate thereof cures under mild conditions into a water/oil repellent layer having abrasion resistance, weatherability and low dynamic friction.Type: GrantFiled: March 18, 2015Date of Patent: October 9, 2018Assignee: Shin-Etsu Chemical Co., Ltd.Inventors: Ryusuke Sakoh, Takashi Matsuda, Yuji Yamane
-
Patent number: 10093774Abstract: Provided are a modified polyphenylene ether resin, a method of making the same and a resin composition. Particularly, the modified polyphenylene ether resin has a structure represented by the following formula (I), wherein R, Y, PPE, Z and c are as described in the specification. Also provided are a method of making the modified polyphenylene ether resin, a resin composition comprising the modified polyphenylene ether resin and an article made from the resin composition. Using the modified polyphenylene ether resin described above can achieve a better glass transition temperature, thermal resistance and lower (superior) thermal expansion and dielectric properties.Type: GrantFiled: August 11, 2016Date of Patent: October 9, 2018Assignee: ELITE ELECTRONICS MATERIAL (KUNSHAN) CO., LTD.Inventors: Chen Yu Hsieh, Yan Zhang
-
Patent number: 10093775Abstract: The present invention aims to provide an aqueous dispersion that contains particles of a fluoropolymer at high concentrations and has a less variable pH, and in which aggregates are less likely to be generated even after the aqueous dispersion has been stored for a long time. The present invention relates to an aqueous dispersion, including: particles of a fluoropolymer having an average primary particle size of 0.1 to 0.5 ?m in an amount of 50 to 70% by mass; a nonionic surfactant in an amount of 2 to 10% by mass based on the amount of the fluoropolymer; and ammonium lauryl sulfate in an amount of 0.0001 to 1% by mass based on the amount of the fluoropolymer, wherein an amount of a fluorine-containing anionic surfactant is less than 10 ppm.Type: GrantFiled: October 21, 2016Date of Patent: October 9, 2018Assignee: DAIKIN INDUSTRIES, LTD.Inventors: Nobuhiko Tsuda, Hiromichi Momose, Toshirou Miura
-
Patent number: 10093776Abstract: A heat-sensitive functional additive is protected from multiple heat histories by being mixed at ambient temperature with a pre-formed masterbatch, for let down into thermoplastic resin at the time of final-shaping of the plastic article.Type: GrantFiled: July 13, 2015Date of Patent: October 9, 2018Assignee: PolyOne-Shanghai, ChinaInventors: Mengge Liu, Yonghua Rhett Liu, Wenyu Shang, Yinyin Zhao
-
Patent number: 10093777Abstract: A fiber-reinforced resin sheet and an integrally molded article are provided. The fiber-reinforced resin sheet comprises a nonwoven fabric made of reinforcing fibers having a thermoplastic resin (A) impregnated on one side of the nonwoven fabric. The fiber-reinforced resin sheet satisfies any one of the following conditions (I) and (II): (I) the nonwoven fabric has an area wherein the reinforcing fibers constituting the nonwoven fabric are exposed on the other side in the thickness direction of the nonwoven fabric, and (II) the nonwoven fabric has a thermoplastic resin (B) impregnated on the other side in thickness direction of the nonwoven fabric, and the nonwoven fabric has a reinforcing fiber volume ratio Vfm of up to 20% by volume, and wherein the thermoplastic resin (A) and the thermoplastic resin (B) form an interface layer in the sheet, and the interface layer has a concave-convex shape with a maximum height Ry of at least 50 ?m and an average roughness Rz of at least 30 ?m.Type: GrantFiled: December 6, 2013Date of Patent: October 9, 2018Assignee: TORAY INDUSTRIES, INC.Inventors: Yoshiki Takebe, Hiroki Kihara, Noriyuki Hirano